We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$17.8B
AUM Growth
+$1.56B
(+9.6%)
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
7.26%
Top 10 Holdings %
Top 10 Hldgs %
44.67%
Holding
3,394
New
1,168
Increased
565
Reduced
380
Closed
1,233
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$218M |
| 2 |
Super Micro Computer
SMCI
|
+$199M |
| 3 |
Apple
AAPL
|
+$185M |
| 4 |
Amazon
AMZN
|
+$174M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.3B |
| 2 |
Merck
MRK
|
+$203M |
| 3 |
Workday
WDAY
|
+$178M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$176M |
| 5 |
CRH
CRH
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Industrials | 7.93% |
| 3 | Consumer Discretionary | 7.91% |
| 4 | Financials | 7.65% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Aclaris Therapeutics
ACRS
$851M
| $89K | ﹤0.01% |
+81,005
| New | +$95.2K |
|
|
BCG
1777
Binah Capital Group
BCG
$23.7M
| $88K | ﹤0.01% |
+14,239
| New | +$97.8K |
|
1778
ESS Tech
GWH
$19.8M
| $87K | ﹤0.01% |
+7,126
| New | +$80.3K |
|
1779
BioAtla
BCAB
$5.53M
| $86K | ﹤0.01% |
+1,256
| New | +$149K |
|
1780
Nuvectis Pharma
NVCT
$614M
| $86K | ﹤0.01% |
+13,627
| New | +$92.6K |
|
|
LICY
1781
DELISTED
Li-Cycle Holdings Corp.
LICY
| $86K | ﹤0.01% |
13,269
+3,218
| +32% | +$17.8K |
|
1782
Evolution Petroleum
EPM
$127M
| $85K | ﹤0.01% |
+16,247
| New | +$91.2K |
|
|
FIRY
1783
Firy Inc
FIRY
$156M
| $85K | ﹤0.01% |
+11,891
| New | +$77.3K |
|
1784
Virgin Galactic
SPCE
$377M
| $85K | ﹤0.01% |
+10,156
| New | +$184K |
|
1785
Telefônica Brasil
VIV
$19.3B
| $84K | ﹤0.01% |
+10,254
| New | +$92.7K |
|
1786
Vuzix
VUZI
$215M
| $82K | ﹤0.01% |
+61,435
| New | +$84.7K |
|
1787
Blue Ridge Bankshares
BRBS
$331M
| $81K | ﹤0.01% |
+31,305
| New | +$87.4K |
|
|
ABLLW
1788
DELISTED
Abacus Life Warrant
ABLLW
| $78K | ﹤0.01% |
110,476
+2,500
| +2% | +$1.24K |
|
1789
Santander
BSBR
$43.4B
| $78K | ﹤0.01% |
15,938
+618
| +4% | +$3.31K |
|
1790
Adicet Bio
ACET
$74.1M
| $77K | ﹤0.01% |
+3,995
| New | +$107K |
|
1791
eHealth
EHTH
$42.9M
| $77K | ﹤0.01% |
+17,062
| New | +$85.9K |
|
|
GUT
1792
Gabelli Utility Trust
GUT
$558M
| $77K | ﹤0.01% |
+13,489
| New | +$76.6K |
|
1793
Intensity Therapeutics
INTS
$11.5M
| $77K | ﹤0.01% |
+635
| New | +$72K |
|
|
LEO
1794
BNY Mellon Strategic Municipals
LEO
$384M
| $77K | ﹤0.01% |
+12,632
| New | +$75.7K |
|
|
AIIO
1795
Robo.ai Inc
AIIO
$509M
| $75K | ﹤0.01% |
2,947
+277
| +10% | +$25K |
|
1796
SKYX Platforms
SKYX
$160M
| $74K | ﹤0.01% |
+78,700
| New | +$77K |
|
1797
Sportsman's Warehouse
SPWH
$46M
| $72K | ﹤0.01% |
+29,970
| New | +$95.2K |
|
|
DFSC
1798
DEFSEC Technologies
DFSC
$3.28M
| $71K | ﹤0.01% |
+745
| New | +$97.5K |
|
|
OPTN
1799
DELISTED
OptiNose
OPTN
| $71K | ﹤0.01% |
+4,610
| New | +$77.2K |
|
|
SUPV
1800
Grupo Supervielle
SUPV
$763M
| $71K | ﹤0.01% |
+10,499
| New | +$68.4K |
|
Similar funds
DB
HRT Financial's Q2 2024 Portfolio in Review
As of Q2 2024, HRT Financial held 3,394 positions worth $17.8B, up 9.6% from $16.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
HRT Financial deployed $1.29B of net new capital in Q2 2024, opening 1,168 new positions and adding to 565 existing holdings. Its largest new stake was ExxonMobil: 1,873,568 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.5% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.3B trimmed.
- HRT Financial's largest Q2 2024 buy was ExxonMobil: 1,873,568 shares worth $216M.
- HRT Financial added most to Apple in Q2 2024, an estimated $185M increase.
- HRT Financial's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.3B.
- HRT Financial fully exited Merck in Q2 2024, selling an estimated $203M.
- HRT Financial's ten largest holdings make up 45% of its $17.8B portfolio in Q2 2024.
- HRT Financial opened 1,168 new positions and closed 1,233 in Q2 2024.
- HRT Financial's portfolio value rose 9.6% quarter-over-quarter to $17.8B.
Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.